About: The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1984

Attributes	Values
rdf:type	Item
description	наукова стаття, опублікована в червні 1984 (uk) article scientifique publié en 1984 (fr) im Juni 1984 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1984 (ast) scientific article published on 01 June 1984 (en)
publication date	wds:Q71010684-BE4C0553-7C20-44AC-8B76-CAD57D5ED9EB
publication date	1984-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q71010684-370E9110-915B-4F4F-864D-8CB166F039CE
language of work or name	English
author name string	wds:Q71010684-A1820169-EF59-478E-8E33-84A3BC348183
author name string	P Anderson
rdfs:label	The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b (en)
skos:prefLabel	The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b (en)
name	The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b (en)
title	wds:Q71010684-6435674C-51A8-4CBD-8DC9-2433AB014249
title	The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b (en)
page(s)	wds:Q71010684-7662678F-B510-4946-AA63-085967425E3D
page(s)	1034-1035
instance of	wds:Q71010684-87FB62C4-6DCE-4A89-96B7-59369400E2AA
instance of	scholarly article
main subject	wds:Q71010684-976064E5-B1D2-46C0-BA3D-7B5E9695C42D wds:Q71010684-DB0F4C2D-51A3-4CC1-BF53-60884154FF1B
main subject	Haemophilus influenzae polysaccharide
PubMed ID	wds:Q71010684-D3015B0E-610F-4157-B1FE-C55F88291B09
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6610714
PubMed ID	6610714
published in	wds:Q71010684-39AD5486-8217-4A0B-A060-084924EB1E08
published in	Journal of Infectious Diseases
issue	wds:Q71010684-829483F6-CB0D-4617-9CC0-0C9635336F30
volume	wds:Q71010684-04071CA2-D040-4CE4-ABF3-9252EFFA98B6
issue	6
volume	149
DOI	wds:Q71010684-C6238732-AC87-4FF0-A7A1-36BED044B53A
DOI	http://dx.doi.org/10.1093/INFDIS/149.6.1034
DOI	10.1093/INFDIS/149.6.1034
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71010684
is cites work of	Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old children Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations Comparison of a multiplex flow cytometric assay with enzyme-linked immunosorbent assay for auantitation of antibodies to tetanus, diphtheria, and Haemophilus influenzae Type b Vaccines for cocaine abuse Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide Effect of combination with an acellular pertussis, diphtheria, tetanus vaccine on antibody response to Hib vaccine (PRP-T) Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides Immunisation of premature infants. Clinical relevance of lower Hib response in DTPa-based combination vaccines Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation Immunization of 2-month-old infants with protein-coupled oligosaccharides derived from the capsule of Haemophilus influenzae type b Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned Pneumococcal vaccine. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in Korean infants: a meta-analysis Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America A competitive enzyme-linked immunosorbent assay for measuring the levels of serum antibody to Haemophilus influenzae type b Humoral immunity and bronchiectasis Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines Paediatric acute epiglottitis: not a disappearing entity Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered Smith-Magenis Syndrome Patients Often Display Antibody Deficiency but Not Other Immune Pathologies Safety and immunogenicity of a diphtheria, tetanus, acellular pertussis and Haemophilus influenzae Type b combination vaccine compared with separate administration of licensed equivalent vaccines in Chinese infants and toddlers for primary and boost Serocorrelates of protection against infant group B streptococcus disease Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197 Protein conjugate vaccines--how much is enough? Meningococcal groups C and Y and haemophilus B tetanus toxoid conjugate vaccine (HibMenCY-TT; MenHibrix(®)): a review Defective anti-polysaccharide IgG vaccine responses in IgA deficient mice. Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Con Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled tria Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old. Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results fr Successful Vaccines Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine.
is cites work of	wds:Q33889533-2AF420DA-54BD-4C35-8F82-B25C1D590884 wds:Q35940648-30DBBF38-18CB-4097-A030-C4C9E163F273 wds:Q39643806-E48FD78E-2FCA-4AA1-AD03-F6C7EA090A76 wds:Q40201775-D561D12D-D5F8-4804-A973-1C8D1878E7C4 wds:Q40297517-6F5CD491-CCCF-4188-93A0-BB57BB4FA6D9 wds:Q39882143-D937736C-0076-4F25-9E66-8871280DF476 wds:Q38104685-E9016A25-EAF1-4CCA-AA76-A09CA61558E5 wds:Q42909238-9E20EF59-96F3-4E8B-9D28-9D1B5B485405 wds:Q40412943-7D5EC81F-56DB-4455-8982-2E80007BD403 wds:Q51969880-7B0D090A-98CB-446A-861C-C3D727D84651 wds:Q77296857-818DFEF3-0C5B-4B44-ACE2-CCEA843B5058 wds:Q78402125-AABE78C6-EC1C-4446-9F55-A9A316B95E1D wds:Q91494915-AF8D189E-A2FE-41E6-A404-26FECF68FC43 wds:Q34516546-795AF2B3-EE2C-4F79-BC14-E9842349C3BD wds:Q37067275-2D6EB29D-CF7A-4110-B6C0-C9478A62D263

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software